Authors:
Gouarin, S
Palmer, P
Cointe, D
Rogez, S
Vabret, A
Rozenberg, F
Denis, F
Freymuth, F
Lebon, P
Grangeot-Keros, L
Citation: S. Gouarin et al., Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR, J CLIN VIRO, 21(1), 2001, pp. 47-55
Authors:
Baccard-Longere, M
Freymuth, F
Cointe, D
Seigneurin, JM
Grangeot-Keros, L
Citation: M. Baccard-longere et al., Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity, CL DIAG LAB, 8(2), 2001, pp. 429-431
Authors:
Emilie, D
Burgard, M
Lascoux-Combe, C
Laughlin, M
Krzysiek, R
Pignon, C
Rudent, A
Molina, JM
Livrozet, JM
Souala, F
Chene, G
Grangeot-Keros, L
Galanaud, P
Sereni, D
Rouzioux, C
Citation: D. Emilie et al., Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study, AIDS, 15(11), 2001, pp. 1435-1437
Authors:
Krzysiek, R
Rudent, A
Bouchet-Delbos, L
Foussat, A
Boutillon, C
Portier, A
Ingrand, D
Sereni, D
Galanaud, P
Grangeot-Keros, L
Emilie, D
Citation: R. Krzysiek et al., Preferential and persistent depletion of CCR5(+) T-helper lymphocytes withnonlymphoid homing potential despite early treatment of primary HIV infection, BLOOD, 98(10), 2001, pp. 3169-3171
Authors:
Llorente, L
Richaud-Patin, Y
Garcia-Padilla, C
Claret, E
Jakez-Ocampo, J
Cardiel, MH
Alcocer-Varela, J
Grangeot-Keros, L
Alarcon-Segovia, D
Wijdenes, J
Galanaud, P
Emilie, D
Citation: L. Llorente et al., Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus, ARTH RHEUM, 43(8), 2000, pp. 1790-1800
Authors:
Belanger, P
Derouin, F
Grangeot-Keros, L
Meyer, L
Citation: P. Belanger et al., Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995, CLIN INF D, 28(3), 1999, pp. 575-581